Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 90, Issue 3, 2010, Pages 261-269

  Zhou, Yijun ^a   Li, Yan ^a   Zhang, Dan ^a   Wang, Jiahe ^a   Yang, Hongwu ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Liaoning Provincial Center for Disease Control and Prevention   (China)

Author keywords

Bone mineral density; Bone turnover; Dual X ray absorptiometry (DXA); Osteopenia; Osteoporosis; Postmenopausal; Type 2 diabetes

Indexed keywords

INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; OSTEOCALCIN; SEX HORMONE; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HIP; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LUMBAR SPINE; MAJOR CLINICAL STUDY; MINERAL METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSSIFICATION; OSTEOPENIA; POSTMENOPAUSE OSTEOPOROSIS; PREDICTION; PREVALENCE; PROTEIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY; BONE DISEASES, METABOLIC; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HIP; HUMANS; INSULIN; LUMBAR VERTEBRAE; MIDDLE AGED; OBESITY; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PREVALENCE;

EID: 78649452367     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.09.013     Document Type: Article

References (42)

1. Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362:1090-1101.
2. Wang Y., Tao Y., Hyman M.E., Li J., Chen Y. Osteoporosis in china. Osteoporos Int 2009, 20:1651-1662.
3. Meyer H.E., Tverdal A., Falch J.A. Risk factors for hip fracture in middle-aged Norwegian women and men. Am J Epidemiol 1993, 137:1203-1211.
4. Forsen L., Meyer H.E., Midthjell K., Edna T.H. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 1999, 42:920-925.
5. Nicodemus K.K., Folsom A.R. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001, 24:1192-1197.
6. Melton L.J., Kan S.H., Frye M.A., Wahner H.W., O'Fallon W.M., Riggs B.L. Epidemiology of vertebral fractures in women. Am J Epidemiol 1989, 129:1000-1011.
7. Suzuki T. Risk factors for osteoporosis in Asia. J Bone Miner Metab 2001, 19:133-141.
8. Barrett-Connor E., Siris E.S., Wehren L.E., Miller P.D., Abbott T.A., Berger M.L., et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res 2005, 20:185-194.
9. Bartos V., Jirkovska A., Kasalicky P., Smahelova A., Vondra K., Skibova J. Osteopenia and osteoporosis in diabetic women over 40 years of age. Cas Lek Cesk 2001, 140:299-301.
10. Sert M., Tetiker T., Kirim S., Soyupak S., Canataroglu A., Kocak M. Type 2 diabetes mellitus and osteopenia: is there an association?. Acta Diabetol 2003, 40:105-108.
11. Akin O., Gol K., Akturk M., Erkaya S. Evaluation of bone turnover in postmenopausal type 2 diabetic patients using biochemical markers and bone mineral density measurements. Gynecol Endocrinol 2003, 17:19-29.
12. Majima T., Komatsu Y., Yamada T., Koike Y., Shigemoto M., Takagi C., et al. Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int 2005, 16:907-913.
13. Rakic V., Davis W.A., Chubb S.A.P., Islam F.M.A., Prince R.L., Davis T.M.E. Bone mineral density and its determinants in diabetes: The Fremantle Diabetes Study. Diabetologia 2006, 49:863-871.
14. Leidig-Bruckner G., Ziegler R. Diabetes mellitus a risk for osteoporosis?. Exp Clin Endocrinol Diabetes 2001, 109(Suppl. 2):S493-S514.
15. de Liefde I.I., van der Klift M., de Laet C.E.D.H., van Daele P.L.A., Hofman A., Pols H.A.P. Bone mineral density and fracture risk in type-2 diabetes mellitus: The Rotterdam Study. Osteoporos Int 2005, 16:1713-1720.
16. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int 2007, 18:427-444.
17. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
18. Gu D., Reynolds K., Wu X., Chen J., Duan X., Reynolds R.F., et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005, 365:1398-1405.
19. Torrens J.I., Skurnick J., Davidow A.L., Korenman S.G., Santoro N., Soto-Greene M., et al. Study of women's health across the nation (SWAN). Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early premenopausal women without diabetes: the study of women's health across the nation (SWAN). Diabetes Care 2004, 27:354-361.
20. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. WHO technical report series no. 843. Geneva; 1994. p. 1-129.
21. World Health Organization The Asia-Pacific perspective: redefining obesity and its treatment 2000, World Health Organization, Geneva.
22. Finkelstein J.S., Lee M.-L.T., Sowers M., Ettinger B., Neer R.M., Kelsey J.L., et al. Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab 2002, 87:3057-3067.
23. Shan P.F., Wu X.P., Zhang H., Cao X.Z., Gu W., Deng X.G., et al. Bone mineral density and its relationship with body mass index in postmenopausal women with type 2 diabetes mellitus in mainland China. J Bone Miner Metab 2009, 27:190-197.
24. Melton L.J., Leibson C.L., Achenbach S.J., Therneau T.M., Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 2008, 23:1334-1342.
25. Anaforoglu I., Nar-Demirer A., Bascil-Tutuncu N., Ertorer M.E. Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes. J Diabetes Complicat 2009, 23:12-17.
26. Schwartz A.V., Sellmeyer D.E., Ensrud K.E., Cauley J.A., Tabor H.K., Schreiner P.J., et al. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 2001, 86:32-38.
27. Espallargues M., Sampietro-Colom L., Estrada M.D., Sola M., del Rio L., Setoain J., et al. Identifying bone-mass related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int 2001, 12:811-822.
28. de Luis Roman D.A., Aller R., Perez Castrillon J.L., De Luis J., Gonzales Sagrado M., Izaola O., et al. Effects of dietary intake and life style on bone density in patients with diabetes mellitus. Ann Nutr Metab 2004, 48:141-145.
29. Lau E.M., Leung P.C., Kwok T., Woo J., Lynn H., Orwoll E., et al. The determinants of bone mineral density in Chinese men-results from Mr. Os (Hong Kong), the first cohort study on osteoporosis in Asian men. Osteoporos Int 2006, 17:297-303.
30. Ensrud K.E., Ewing S.K., Stone K.L., Cauley J.A., Bowman P.J., Cummings S.R. Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women. J Am Geriatr Soc 2003, 51:1740-1747.
31. Vanitallie T.B. Fragility in the elderly: contributions of sarcopenia and visceral protein depletion. Metabolism 2003, 52:22-26.
32. Slemenda C.W. Body composition and skeletal density-mechanical loading or something more?. J Clin Endocrinol Metab 1995, 80:1761-1763.
33. Reid I.R., Evans M.C., Cooper G.J., Ames R.W., Stapleton J. Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol 1993, 265:E655-E659.
34. Stolk R.P., van Daele P.L., Pols H.A., Burger H., Hofman A., Birkenhager J.C., et al. Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study. Bone 1996, 18:545-549.
35. Barrett-Connor E., Kritz-Silverstein D. Does hyperinsulinemia preserve bone?. Diabetes Care 1996, 19:1388-1392.
36. Yano H., Ohya K., Amagasa T. Insulin enhancement of in vitro wound healing in fetal rat parietal bones. J Oral Maxillofac Surg 1996, 54:182-186.
37. Kumeda Y. Osteoporosis in diabetes. Clin Calcium 2008, 18:589-599.
38. Brown S.A., Sharpless J.L. Osteoporosis: an underappreciated complication of diabetes. Clin Diabetes 2004, 22:10-20.
39. Achemlal L., Tellal S., Rkiouak F., Nouijai A., Bezza A., Derouiche M., et al. Bone metabolism in male patients with type 2 diabetes. Clin Rheumatol 2005, 24:493-496.
40. He H., Liu R., Desta T., Leone C., Gerstenfeld L.C., Graves D.T. Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology 2004, 145:447-452.
41. Kress B.C, Mizrahi I.A., Armour K.W., Marcus R., Emkey R.D., 2nd Santora A.C. Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women. Clin Chem 1999, 45:1009-1017.
42. Petit M.A., Paudel M.L., Taylor B.C., Hughes J.M., Strotmeyer E.S., Schwartz A.V., et al. Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res 2010, 25:285-291.